| Literature DB >> 32787112 |
Sho Nakamura1, Misa Sayama1, Akiharu Uwamizu2,3,4, Sejin Jung1, Masaya Ikubo1, Yuko Otani1, Kuniyuki Kano2,3,4, Jumpei Omi2,3,4, Asuka Inoue3,5,4, Junken Aoki2,3,4,6, Tomohiko Ohwada1.
Abstract
Lysophosphatidylserine (LysoPS), an endogenous ligand of G protein-coupled receptors, consists of l-serine, glycerol, and fatty acid moieties connected by phosphodiester and ester linkages, respectively. An ester linkage of phosphatidylserine can be hydrolyzed at the 1-position or at the 2-position to give 2-acyl lysophospholipid or 1-acyl lysophospholipid, respectively. 2-Acyl lysophospholipid is in nonenzymatic equilibrium with 1-acyl lysophospholipid in vivo. On the other hand, 3-acyl lysophospholipid is not found, at least in mammals, raising the question of whether the reason for this might be that the 3-acyl isomer lacks the biological activities of the other isomers. Here, to test this idea, we designed and synthesized a series of new 3-acyl lysophospholipids. Structure-activity relationship studies of more than 100 "glycol surrogate" derivatives led to the identification of potent and selective agonists for LysoPS receptors GPR34 and P2Y10. Thus, the non-natural 3-acyl compounds are indeed active and appear to be biologically orthogonal with respect to the physiologically relevant 1- and 2-acyl lysophospholipids.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32787112 DOI: 10.1021/acs.jmedchem.0c01126
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446